Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 747,888 | 597,395 | 394,796 | 551,192 | 286,668 |
| Marketable Securities | N/A | N/A | N/A | N/A | 231,446 |
| Receivables | 24,649 | 49,166 | 3,094 | 2,753 | 9,090 |
| Other current assets | 28,566 | 38,107 | 40,247 | 15,869 | 7,514 |
| TOTAL | $812,845 | $714,269 | $438,137 | $569,814 | $534,718 |
| Non-Current Assets | |||||
| PPE Net | 103,931 | 141,063 | 86,510 | 88,192 | 64,725 |
| Intangibles | 472,061 | 484,728 | 88,499 | 2,107 | 2,186 |
| Other Non-Current Assets | 85,293 | 108,538 | 40,553 | 41,175 | 8,716 |
| TOTAL | $661,285 | $734,329 | $215,562 | $131,474 | $75,627 |
| Total Assets | $1,474,130 | $1,448,598 | $653,699 | $701,288 | $610,345 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,118 | 21,613 | 3,953 | 4,586 | 2,819 |
| Accrued Expenses | 70,230 | 81,872 | 46,635 | 32,904 | 32,333 |
| Other current liabilities | 37,605 | 61,767 | 36,426 | 56,726 | 10,000 |
| TOTAL | $147,707 | $187,472 | $93,171 | $100,265 | $46,658 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,564 | 19,022 | 1,101 | 536 | 633 |
| Other Non-Current Liabilities | 162,739 | 190,747 | 94,652 | 114,681 | 16,006 |
| TOTAL | $195,558 | $226,344 | $97,092 | $115,217 | $20,749 |
| Total Liabilities | $343,265 | $413,816 | $190,263 | $215,482 | $67,407 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 527,398 | 401,991 | 234,653 | 191,233 | 170,774 |
| Common Shares | 5 | 4 | 2 | 2 | 2 |
| Retained earnings | -2,076,002 | -1,431,283 | -967,622 | -639,556 | -400,080 |
| Other shareholders' equity | 36,717 | -7,637 | 0 | 0 | -126 |
| TOTAL | $1,130,865 | $1,034,782 | $463,436 | $485,806 | $542,938 |
| Total Liabilities And Equity | $1,474,130 | $1,448,598 | $653,699 | $701,288 | $610,345 |